RE:RE:RE:Will MCNA soon be obsolete?Little Lady, you are obviously a smart individual. How many pre clinical cancer companies make it to a BLA? After the 3-400 mil in sunk costs. 2%? 4%? Maybe. Yet nearly every one that is publicly traded on a North American exchange enjoys a higher market cap in P1. Time for a mangement change perhaps?